https://www.pharmacytimes.com/view/vitamin-c-may-help-reduce-toxic-adverse-effects-of-common-cancer-treatment
“Our results suggest vitamin C as a potential adjunct therapy to assist in the management of peripheral muscle disorders after treatment with doxorubicin, thereby improving functional capacity and quality of life and reducing mortality,” Antonio Viana do Nascimento Filho, a master’s student in medicine at University Nove de Julho in Brazil, said in a statement.